Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients
2007
Progress report of a randomized trial comparing long‐term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China
2013
A new applicator design for endocavitary brachytherapy of cancer in the nasopharynx
1997
Head and neck squamous cell carcinoma
2020 Standout
Nasopharyngeal carcinoma
2005 Standout
Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial
2011
Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma
2003
Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity
2001
Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area
2015
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Gum Arabic as a Phytochemical Construct for the Stabilization of Gold Nanoparticles: In Vivo Pharmacokinetics and X‐ray‐Contrast‐Imaging Studies
2007 Standout
Distant Metastases from Nasopharyngeal Cancer
2001
Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer
2001
The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase iii randomized trials
2010
Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy
2016
Staging of nasopharyngeal carcinoma: From Ho's to the new UICC system
1999
Timing of Chemoradiotherapy and Patient Selection for Locally Advanced Nasopharyngeal Carcinoma
2003
Quantifying the degree of conformity in radiosurgery treatment planning
2003
Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma
2010
Head and neck cancer
2008 Standout
Locally Recurrent Nasopharyngeal Carcinoma: Treatment Results for Patients with Computed Tomography Assessment
1998
Detection of Stage I nasopharyngeal carcinoma by serologic screening and clinical examination
2011
Nasopharyngeal carcinoma
2019 Standout
Long-term Outcomes and Prognostic Factors of Re-irradiation for Locally Recurrent Nasopharyngeal Carcinoma using Intensity-modulated Radiotherapy
2011
Comparison of AJCC 1988 and 1997 classifications for nasopharyngeal carcinoma
1999
High Dose Rate Intracavitary Brachytherapy in the Treatment of Nasopharyngeal Carcinoma
1996
Radiation burden of patients undergoing endovascular abdominal aortic aneurysm repair
2009
Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation
2005
Conformity index: A review
2006 Standout
Quantitative analysis of plasma cell–free Epstein‐Barr virus DNA in nasopharyngeal carcinoma after salvage nasopharyngectomy: A prospective study
2004
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma
2008
How Does Magnetic Resonance Imaging Influence Staging According to AJCC Staging System for Nasopharyngeal Carcinoma Compared With Computed Tomography?
2008
The time course of histologic remission after treatment of patients with nasopharyngeal carcinoma
1999
A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma
2014
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Long-Term Prognostic Effects of Plasma Epstein-Barr Virus DNA by Minor Groove Binder-Probe Real-Time Quantitative PCR on Nasopharyngeal Carcinoma Patients Receiving Concurrent Chemoradiotherapy
2007
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Radiation Dose–Volume Effects in the Brain
2010
Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation
2002
Nasopharyngeal carcinoma
2015 Standout
Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: Efficacy and complications
2003
L'effet volume en radiothérapie première partie : effet volume et tumeur
2003
The effect of primary tumor volumes in advanced T‐staged nasopharyngeal tumors
2002
Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy
2012
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience
2002 Standout
Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival
2010
Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control
2004
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
2003 Standout
Noninvasive MR Imaging–guided Focal Opening of the Blood-Brain Barrier in Rabbits
2001 Standout
The battle against nasopharyngeal cancer
2012
Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma
2000
Radioactive gold grain implants in recurrent and locally advanced head-and-neck cancers
2002
Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma
2004
Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma
2003
Effects of Prolongation of Overall Treatment Time Due To Unplanned Interruptions During Radiotherapy of Different Tumor Sites and Practical Methods for Compensation
2007
Radiation Dose–Volume Effects in the Heart
2010
Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma
2000
Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy
2001
Reirradiation of nasopharyngeal carcinoma with intracavitary mold brachytherapy: an effective means of local salvage
2002
Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
2012
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
2011 Standout
Nasopharyngeal Carcinoma: Review of How Imaging Affects Staging
1999
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications
2000
The use of MR imaging to detect residual versus recurrent nasopharyngeal carcinoma following treatment with radiation therapy
2013
Nasopharyngeal cancer WHO type II-III: monoinstitutional retrospective analysis with standard and accelerated hyperfractionated radiation therapy
2002
The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma
2001
Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years’ experience at Long Beach Memorial
2000
Treatment outcome after radiotherapy alone for patients with Stage I–II nasopharyngeal carcinoma
2003
Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis
2015
Radiation‐related cranial nerve palsy in patients with nasopharyngeal carcinoma
2002
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells.
1995 StandoutNobel
Repopulation in murine breast tumors during and after sequential treatments with cyclophosphamide and 5-fluorouracil.
2003
Management of glioblastoma: State of the art and future directions
2020 Standout
The Enigmatic Epidemiology of Nasopharyngeal Carcinoma
2006 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Long-Term Survival After Cisplatin-Based Induction Chemotherapy and Radiotherapy for Nasopharyngeal Carcinoma: A Pooled Data Analysis of Two Phase III Trials
2005
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Nasopharyngectomy for recurrent nasopharyngeal cancer: a 2- to 17-year follow-up.
2002
Serial Therapy-Induced Changes in Tumor Shape in Cervical Cancer and Their Impact on Assessing Tumor Volume and Treatment Response
2006
Quantitative Plasma Hypermethylated DNA Markers of Undifferentiated Nasopharyngeal Carcinoma
2004
Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means
1998
Morphological, Biochemical and Molecular Biology Approaches for the Diagnosis of Lysosomal Storage Diseases
2000
Exosomes as drug delivery vehicles for Parkinson's disease therapy
2015 Standout
A Literature Review of Late Complications of Radiation Therapy for Head and Neck Cancers: Incidence and Dose Response
2013
Plasma Epstein-Barr Viral Deoxyribonucleic Acid Quantitation Complements Tumor-Node-Metastasis Staging Prognostication in Nasopharyngeal Carcinoma
2006
Genetics and Therapies for GM2 Gangliosidosis
2018
Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma
1996
Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight.
1980 Standout
Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease.
1994
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis
2017
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
2018
Long‐term outcomes after reirradiation in nasopharyngeal carcinoma with intensity‐modulated radiotherapy: A meta‐analysis
2017
Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials
2010
Works of P.M. Wu being referenced
A new tool for dose conformity evaluation of radiosurgery treatment plans
1999
Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time
2002
Ionizing radiation absorption of vascular surgeons during endovascular procedures
2007
Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma
1993
Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome
1997
Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma: A significant factor in local control and distant metastasis
1996
The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma
1997
Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma
2005
Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: A prospective study of the effect of radiation and cisplatin treatment
1996
Concurrent and Adjuvant Chemotherapy for Nasopharyngeal Carcinoma: A Factorial Study
2004
Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma
2001
Characterization of a new model of GM2-gangliosidosis (Sandhoff's disease) in Korat cats.
1985